4
Changes in Ownership
BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-075143
EVP, Chief R&D Officer sold 5,147 shares at $58.81 ($302,711)
From the SEC's structured data for this filing
Trades in this filing
Friberg Gregory R · EVP, Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-18 | Sale : show line 1 in the form | −5,147 | $58.81 | $302,711 | 42,585 | D |
| Open-market sales · 5,147 sh · avg $58.81 · $302,711 | ||||||
Loading xslF345X06/wk-form4_1795129447.xml…